101 related articles for article (PubMed ID: 7784254)
1. Identification of a new chromogranin B fragment (314-365) in endocrine tumors.
Woussen-Colle MC; Gourlet P; Vandermeers A; Vandermeers-Piret MC; D'Haens J; Velkeniers B; Robberecht P
Peptides; 1995; 16(2):231-6. PubMed ID: 7784254
[TBL] [Abstract][Full Text] [Related]
2. Evidence that the chromogranin B fragment 368-417 extracted from a pheochromocytoma is phosphorylated.
Dahma H; Gourlet P; Vandermeers A; Vandermeers-Piret MC; Robberecht P
Peptides; 2001 Sep; 22(9):1491-9. PubMed ID: 11514034
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A(210-301) is the major form of pancreastatin-like material in human gut extracts and endocrine tumors.
Woussen-Colle MC; Lingier P; Vertongen P; Vandermeers-Piret MC; Vandermeers A; Robberecht P
Peptides; 1994; 15(5):869-74. PubMed ID: 7984507
[TBL] [Abstract][Full Text] [Related]
4. Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A.
Schmidt WE; Siegel EG; Kratzin H; Creutzfeldt W
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8231-5. PubMed ID: 3186720
[TBL] [Abstract][Full Text] [Related]
5. Pancreastatin: molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues.
Schmidt WE; Siegel EG; Lamberts R; Gallwitz B; Creutzfeldt W
Endocrinology; 1988 Sep; 123(3):1395-404. PubMed ID: 3042370
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A and B in adenomas of the pituitary. An immunohistochemical study of 42 cases.
Schmid KW; Kröll M; Hittmair A; Maier H; Tötsch M; Gasser R; Finkenstett G; Hogue-Angeletti R; Fischer-Colbrie R
Am J Surg Pathol; 1991 Nov; 15(11):1072-7. PubMed ID: 1928557
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla.
Watkinson A; Jönsson AC; Davison M; Young J; Lee CM; Moore S; Dockray GJ
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):471-9. PubMed ID: 1710890
[TBL] [Abstract][Full Text] [Related]
8. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin-B, a putative precursor of eight novel rat glucagonoma peptides through processing at mono-, di-, or tribasic residues.
Nielsen E; Welinder BS; Madsen OD
Endocrinology; 1991 Dec; 129(6):3147-56. PubMed ID: 1954895
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of a tumor-derived human protein related to chromogranin A and its in vitro conversion to human pancreastatin-48.
Tamamura H; Ohta M; Yoshizawa K; Ono Y; Funakoshi A; Miyasaka K; Tateishi K; Jimi A; Yajima H; Fujii N
Eur J Biochem; 1990 Jul; 191(1):33-9. PubMed ID: 2165909
[TBL] [Abstract][Full Text] [Related]
11. Production of GAWK (chromogranin-B 420-493)-like immunoreactivity by endocrine tumors and its possible diagnostic value.
Sekiya K; Ghatei MA; Salahuddin MJ; Bishop AE; Hamid QA; Ibayashi H; Polak JM; Bloom SR
J Clin Invest; 1989 Jun; 83(6):1834-42. PubMed ID: 2723061
[TBL] [Abstract][Full Text] [Related]
12. Chromogranins--new sensitive markers for neuroendocrine tumors.
Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E
Acta Oncol; 1989; 28(3):325-9. PubMed ID: 2545231
[TBL] [Abstract][Full Text] [Related]
13. A polyclonal antiserum against chromogranin A and B--a new sensitive marker for neuroendocrine tumours.
Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E
Acta Endocrinol (Copenh); 1990 Feb; 122(2):145-55. PubMed ID: 2316306
[TBL] [Abstract][Full Text] [Related]
14. Widespread occurrence of chromogranins/secretogranins in the matrix of secretory granules of endocrinologically silent pituitary adenomas.
Rosa P; Bassetti M; Weiss U; Huttner WB
J Histochem Cytochem; 1992 Apr; 40(4):523-33. PubMed ID: 1552186
[TBL] [Abstract][Full Text] [Related]
15. Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors.
Lloyd RV; Cano M; Rosa P; Hille A; Huttner WB
Am J Pathol; 1988 Feb; 130(2):296-304. PubMed ID: 3341449
[TBL] [Abstract][Full Text] [Related]
16. Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity.
Strub JM; Garcia-Sablone P; Lonning K; Taupenot L; Hubert P; Van Dorsselaer A; Aunis D; Metz-Boutigue MH
Eur J Biochem; 1995 Apr; 229(2):356-68. PubMed ID: 7744058
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods.
Stridsberg M; Angeletti RH; Helle KB
J Endocrinol; 2000 Jun; 165(3):703-14. PubMed ID: 10828855
[TBL] [Abstract][Full Text] [Related]
18. Secretion of chromogranin A by peptide-producing endocrine neoplasms.
O'Connor DT; Deftos LJ
N Engl J Med; 1986 May; 314(18):1145-51. PubMed ID: 3007986
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of a tumor-derived human pancreastatin-related protein.
Funakoshi S; Tamamura H; Ohta M; Yoshizawa K; Funakoshi A; Miyasaka K; Tateishi K; Tatemoto K; Nakano I; Yajima H
Biochem Biophys Res Commun; 1989 Oct; 164(1):141-8. PubMed ID: 2803289
[TBL] [Abstract][Full Text] [Related]
20. Expression of the neuroendocrine cell marker 7B2 in human ACTH secreting tumours.
Vieau D; Linard CG; Mbikay M; Lenne F; Chretien M; Luton JP; Bertagna X
Clin Endocrinol (Oxf); 1992 Jun; 36(6):597-603. PubMed ID: 1424185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
